ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Marketable securities, non-current

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndMarketable securities, non-current (Million USD)YoY (%)
Dec 31, 2025918+3.61%
Dec 31, 2024886+10.89%
Dec 31, 2023799+4.31%
Dec 31, 2022766-6.13%
Dec 31, 2021816-0.61%
Dec 31, 2020821-7.02%
Dec 31, 2019883-1.56%
Dec 31, 2018897+1.59%
Dec 31, 2017883-70.04%
Dec 31, 20162,947-27.07%
Dec 31, 20154,041+3295.80%
Dec 31, 2013119-68.54%
Dec 31, 2011378+25.22%
Dec 31, 2010302

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat